Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Virios Therapeutics Inc (VIRI)

Virios Therapeutics Inc (VIRI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.1550 +0.0171 (+12.40%) 10/08/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.1550 unch (unch) -
Quote Overview for Tue, Oct 8th, 2024
Day Low
0.1430
Day High
0.2068
Open 0.2000
Previous Close 0.1379 0.1379
Volume 42,675,600 42,675,600
Avg Vol 2,719,065 2,719,065
Stochastic %K 22.52% 22.52%
Weighted Alpha -74.16 -74.16
5-Day Change -0.0008 (-0.51%) -0.0008 (-0.51%)
52-Week Range 0.1260 - 1.0400 0.1260 - 1.0400
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,985
  • Shares Outstanding, K 19,258
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,300 K
  • EBIT $ -5 M
  • EBITDA $ -5 M
  • 60-Month Beta 1.58
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.23
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.24
  • Most Recent Earnings $-0.05 on 08/08/24
  • Next Earnings Date 11/11/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.06
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1260 +23.02%
on 10/07/24
Period Open: 0.1780
0.2282 -32.08%
on 09/17/24
-0.0230 (-12.92%)
since 09/06/24
3-Month
0.1260 +23.02%
on 10/07/24
Period Open: 0.2550
0.3329 -53.44%
on 07/18/24
-0.1000 (-39.22%)
since 07/08/24
52-Week
0.1260 +23.02%
on 10/07/24
Period Open: 0.8112
1.0400 -85.10%
on 11/10/23
-0.6562 (-80.89%)
since 10/06/23

Most Recent Stories

More News
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)

VIRI : 0.1550 (+12.40%)
DWTX : 5.64 (-5.69%)
Virios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal

Virios Therapeutics Inc. (NASDAQ: VIRI) is a developmental-stage biotechnology company specializing in novel antiviral therapies for treating fibromyalgia

VIRI : 0.1550 (+12.40%)
AGN : 193.02 (+0.02%)
LLY : 822.51 (+0.10%)
PFE : 25.21 (+0.80%)
GPS : 24.55 (+4.38%)
Virios Therapeutics, Inc. to Present at the Virtual Planet MicroCap Showcase

Virios Therapeutics, Inc. (Nasdaq: VIRI ), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia...

VIRI : 0.1550 (+12.40%)
Virios Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases...

VIRI : 0.1550 (+12.40%)
Virios Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on Monday, November 14, 2022

Virios Therapeutics, Inc. (Nasdaq: VIRI ), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia...

VIRI : 0.1550 (+12.40%)
Virios Therapeutics, Inc. Announces Closing of Public Offering

Virios Therapeutics, Inc. (Nasdaq: VIRI ), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia,...

VIRI : 0.1550 (+12.40%)
Pre-Market Brief: Stocks Mixed Ahead Of FOMC Meeting

December S&P 500 futures (ESZ22) are moderately down -0.08% this morning after three major US benchmark indices rebounded from 9-week lows to close higher during the regular session as market participants...

ESZ22 : 3,871.47s (-0.66%)
F : 9.72 (-1.82%)
GM : 46.68 (-1.10%)
VIRI : 0.1550 (+12.40%)
ENVX : 7.48 (-6.62%)
CGNX : 30.01 (-2.37%)
CHNG : 27.49 (+0.26%)
UNH : 516.04 (+0.06%)
Virios Therapeutics, Inc. Announces Pricing of Public Offering

Virios Therapeutics, Inc. (Nasdaq: VIRI ), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia,...

VIRI : 0.1550 (+12.40%)
Virios Therapeutics, Inc. Announces Proposed Public Offering

Virios Therapeutics, Inc. (Nasdaq: VIRI ), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia,...

VIRI : 0.1550 (+12.40%)
Virios Therapeutics Announces Top-Line Results from Phase 2b Study of IMC-1 in Fibromyalgia

Virios Therapeutics, Inc. (Nasdaq: VIRI ), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia...

VIRI : 0.1550 (+12.40%)

Business Summary

Virios Therapeutics Inc. is a biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Virios Therapeutics Inc. is based in Alpharetta, Georgia.

See More

Key Turning Points

3rd Resistance Point 0.2573
2nd Resistance Point 0.2321
1st Resistance Point 0.1935
Last Price 0.1550
1st Support Level 0.1297
2nd Support Level 0.1045
3rd Support Level 0.0659

See More

52-Week High 1.0400
Fibonacci 61.8% 0.6909
Fibonacci 50% 0.5830
Fibonacci 38.2% 0.4751
Last Price 0.1550
52-Week Low 0.1260

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies